CB1 antagonist (Suven)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCB1 antagonist (Suven)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorldIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuven Life Sciences Ltd
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A